| PERIOD ENDING | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | 31-Jul-08 | | Total Revenue | 6,747,900 | 5,145,900 | 7,401,100 | 7,738,700 | | Cost of Revenue | 4,756,400 | 3,542,500 | 5,282,500 | 5,421,900 | | | Gross Profit | 1,991,500 | 1,603,400 | 2,118,600 | 2,316,800 | | | Operating Expenses | | Research Development | 255,700 | 219,400 | 270,600 | 238,000 | | Selling General and Administrative | 854,400 | 835,800 | 999,200 | 939,600 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 881,400 | 548,200 | 848,800 | 1,139,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 881,400 | 548,200 | 848,800 | 1,139,200 | | Interest Expense | 269,400 | 274,500 | 288,100 | 270,200 | | Income Before Tax | 612,000 | 273,700 | 560,700 | 869,000 | | Income Tax Expense | 137,200 | 73,500 | 223,100 | 307,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 472,300 | 203,900 | 345,100 | 575,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 472,300 | 203,900 | 345,100 | 575,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $472,300 | $203,900 | $345,100 | $575,200 |
|
0.45% Nasdaq 
0.20%
Income Statement
